Status™ COVID-19/Flu A&B Test

SKU: KS/33225

In Stock

COVID-19, Flu A&B

COVID-19 - Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100% - Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%

Flu A - Sensitivity 91.4%, Specificity 95.7%

Flu B - Sensitivity 87.6%, Specificity 95.9%

CLIA license Required to purchase this product

$299.00

$11.96 USD per test (25 test per box)

Volume Discounts

10-20 boxes $269.00 per box ($10.76 per test)

21-39 boxes $260.25 per box ($10.41 per test)

40-49 boxes $254.25 per box ($10.17 per test)

50+ boxes Request Bulk Discount

Quantity:

Request Bulk Pricing Download Product Brochure Download Product Insert

Step 1 – Prepare the Test

Place the test device on a clean, level surface.
Tear open the Extraction Reagent Capsule and dispense the entire contents into the extraction well.

Step 2 – Collect & Process the Sample

Collect an anterior nasal or nasopharyngeal swab specimen according to the instructions.
Insert the swab into the swab stand.
Rotate the swab 3 times to mix the specimen with the extraction reagent.
Allow the swab to stand for 1 minute.
Rotate the swab 3 more times, then discard the swab.

Step 3 – Activate the Test

Raise the device upright for 1–2 seconds.
Gently tap the device to allow the liquid to flow into the test chamber.
Return the device to a flat surface.

Step 4 – Read the Results

Start a timer and read the results at 15 minutes.
Do not interpret results before 15 minutes or after 20 minutes, as this may produce inaccurate results.

Results Interpretation

Negative

A line appears only at the Control (C) position.
No lines appear at the COVID-19, Flu A, or Flu B positions.

Positive

A Control (C) line plus any test line indicates a positive result:
CoV19 + C = COVID-19 Positive
A + C = Influenza A Positive
B + C = Influenza B Positive
More than one test line may indicate multiple infections and should be confirmed according to laboratory protocol.

Invalid

If the Control (C) line does not appear, the result is invalid.
Repeat the test using a new device and a new specimen.

Status™ COVID-19/Flu A&B Rapid Antigen Test

The Status™ COVID-19/Flu A&B Rapid Antigen Test is a rapid, point-of-care diagnostic assay designed for the simultaneous qualitative detection and differentiation of SARS-CoV-2 (COVID-19), Influenza A, and Influenza B from a single nasal or nasopharyngeal swab specimen. This easy-to-use lateral flow immunoassay delivers reliable results in approximately 15 minutes, helping healthcare professionals quickly identify common respiratory infections and make timely clinical decisions.

Designed for professional use, the Status™ COVID-19/Flu A&B Test provides accurate differentiation between COVID-19 and influenza viruses, which often present with similar symptoms. Its streamlined workflow and dependable performance make it an ideal solution for physician offices, urgent care centers, hospitals, clinics, pharmacies, occupational health programs, and other point-of-care testing environments.

Key Features

Detects COVID-19 (SARS-CoV-2), Influenza A, and Influenza B from a single specimen
Rapid results in approximately 15 minutes
Point-of-care test designed for professional use
Simple workflow with minimal hands-on time
High sensitivity and specificity for confident clinical decision-making
Helps differentiate respiratory infections with similar symptoms
Ideal for hospitals, clinics, urgent care centers, physician offices, and occupational health settings
Individually packaged components for convenience and infection control

Applications

Hospitals & Emergency Departments
Physician Offices
Urgent Care Clinics
Occupational Health
Community Health Centers
Long-Term Care Facilities
Pharmacies & Point-of-Care Testing Sites

This professional-use test offers a fast and dependable solution for identifying COVID-19 and influenza infections, enabling healthcare providers to initiate appropriate patient management while supporting efficient respiratory illness screening.